Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
出版年份 2023 全文链接
标题
Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
作者
关键词
-
出版物
Scientific Reports
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-04-21
DOI
10.1038/s41598-023-33682-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19
- (2023) Jonatan C. S. de Carvalho et al. Viruses-Basel
- Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response
- (2022) James Turnbull et al. JOURNAL OF INFECTIOUS DISEASES
- Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship
- (2022) Damiano D’Ardes et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress
- (2022) Pedro V. da Silva-Neto et al. Biomolecules
- Maresin 1 improves cognitive decline and ameliorates inflammation and blood-brain barrier damage in rats with chronic cerebral hypoperfusion
- (2022) Tian Li et al. BRAIN RESEARCH
- Predictors of mortality of COVID-19 in the general population and nursing homes
- (2021) Pedro Pablo España et al. Internal and Emergency Medicine
- Hematological Abnormalities in COVID-19: A Narrative Review
- (2021) Asma Rahman et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness
- (2021) Grant Barker et al. Journal of Clinical Medicine
- Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19
- (2021) Duco Steven Koenis et al. CIRCULATION RESEARCH
- High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
- (2021) Anne‐Sophie Archambault et al. FASEB JOURNAL
- COVID‐19–related laboratory coagulation findings
- (2021) Katrien M. J. Devreese International Journal of Laboratory Hematology
- Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
- (2021) Younes Zaid et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019
- (2021) Norihiko Goto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
- (2021) Melanie Ricke-Hoch et al. PLoS One
- Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
- (2021) Francesco Palmas et al. PLoS One
- Role of arachidonic cascade in COVID-19 infection: A review
- (2021) Md. Abdur Rahman Ripon et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Liver function as a predictor of mortality in COVID-19: A retrospective study
- (2021) Fikret Salık et al. Annals of Hepatology
- Alterations of Lipid Profile in COVID-19: A Narrative Review
- (2021) Abbas Rezaei et al. CURRENT PROBLEMS IN CARDIOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
- (2020) Wenjie Tian et al. JOURNAL OF MEDICAL VIROLOGY
- Parenteral Fish‐Oil Emulsions in Critically Ill COVID‐19 Emulsions
- (2020) Bruce R. Bistrian JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Letter to the Editor in relation to Bistrian BR. Parenteral fish oil emulsions in critically ill COVID‐19 emulsions [published online ahead of print, 2020 May 8]. JPEN J Parenter Enteral Nutr. 2020;10.1002/jpen.1871
- (2020) Raquel S. Torrinhas et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19
- (2020) Anand V. Kulkarni et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non‐steroidal anti‐inflammatory drugs, prostaglandins and COVID‐19
- (2020) Calum T. Robb et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmaco-Immunomodulatory Therapy in COVID-19
- (2020) John G. Rizk et al. DRUGS
- COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
- (2020) Alexander V. Sorokin et al. FASEB JOURNAL
- Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts
- (2020) Jin Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review (Preprint)
- (2020) Miguel Quirch et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- The cytokine storm and COVID‐19
- (2020) Biying Hu et al. JOURNAL OF MEDICAL VIROLOGY
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
- (2020) Eugenio D. Hottz et al. BLOOD
- Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19
- (2020) Younes Zaid et al. CIRCULATION RESEARCH
- Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease
- (2020) Ajay Gupta et al. MEDICAL HYPOTHESES
- Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- (2020) Benjamin Schwarz et al. JOURNAL OF IMMUNOLOGY
- T cell immunobiology and cytokine storm of COVID‐19
- (2020) Xiao‐Hua Luo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells
- (2019) Minna Holopainen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation
- (2018) Katerina Pyrillou et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Omega-3 Polyunsaturated Fatty Acids in Critically Ill Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis
- (2018) Pascal L. Langlois et al. NUTRITION
- The Lipid Mediator Resolvin D1 Reduces the Skin Inflammation and Oxidative Stress Induced by UV Irradiation in Hairless Mice
- (2018) Priscila Saito et al. Frontiers in Pharmacology
- Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling
- (2017) Rahul Vijay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics
- (2017) Justin T. English et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- A cluster of immunoresolvents links coagulation to innate host defense in human blood
- (2017) Paul C. Norris et al. Science Signaling
- Inflammatory responses and inflammation-associated diseases in organs
- (2017) Linlin Chen et al. Oncotarget
- mixOmics: An R package for ‘omics feature selection and multiple data integration
- (2017) Florian Rohart et al. PLoS Computational Biology
- A cluster of immunoresolvents links coagulation to innate host defense in human blood
- (2017) Paul C. Norris et al. Science Signaling
- The inflammatory response triggered by Influenza virus: a two edged sword
- (2016) Luciana P. Tavares et al. INFLAMMATION RESEARCH
- The resolution of inflammation: Principles and challenges
- (2015) Sarah E. Headland et al. SEMINARS IN IMMUNOLOGY
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages
- (2014) François Coulombe et al. IMMUNITY
- Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages
- (2014) Bin Deng et al. PLoS One
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation
- (2013) Vincent C. Tam et al. CELL
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Use of an Inflammation-Modulating Diet in Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-Analysis of Outcome Data
- (2008) Alessandro Pontes-Arruda et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started